← All indications
Prolapse
The protrusion of an organ or part of an organ into a natural or artificial orifice.
Subtype terms (1)
More specific conditions that are subtypes of Prolapse in the MeSH hierarchy.
- Pelvic Organ Prolapse
38 drugs (24 approved, 14 experimental)
Drugs by status
Phase 4 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (26)
- Medicis
- Astellas
- Merck
- Pfizer
- Kenneth Beer
- Policlinico Universitario, Catania
- Beer, Kenneth R., M.D., PA
- University of Pittsburgh
- Atlantic Health System
- Brown University
- Case Western Reserve University
- Kettering Health Network
- University of Louisville
- University of Oslo
- Stony Brook University
- University of Catania
- University of Connecticut
- University of Copenhagen
- TriHealth
- Medical University of Vienna
- Cincinnati Urogynocolgy Associates
- University of North Carolina at Chapel Hill
- University of Alabama, Birmingham
- Universidade Federal do Parana
- American Urogynecologic Society
- The University of Texas, Dallas
Organization Involved with Phase 3 Indications (15)
- Ochsner Health System
- University of Toronto
- Aga Khan University
- Peking University
- Sinai Health System
- University of Western Brittany
- University of Lille
- University of Massachusetts
- Kuopio University Hospital
- University of Paris
- University of Rennes
- Rouen Normandy University
- University of Caen-Normandie
- University of Picardie Jules Verne
- Eyelid and Facial Consultants, New Orleans
Organization Involved with Phase 2 Indications (5)
Organization Involved with Other Experimental Indications (11)
- National Institutes of Health (NIH)
- Harvard University
- University of Maryland
- University of Rochester
- Icahn School of Medicine at Mount Sinai
- University Hospital, Rijeka
- Vita-Salute University of Milano. Italy
- University of Tennessee, Chattanooga
- American Association of Gynecologic Laparoscopists
- Theralogix LLC
- General Hospital Pula